These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Treatment of remitting forms of multiple sclerosis]. Lubetzki C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):996-1000. PubMed ID: 11787366 [TBL] [Abstract][Full Text] [Related]
6. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
7. [Multiple sclerosis: between wish and reality]. Kümpfel T; Hohlfeld R MMW Fortschr Med; 2005 May; 147 Spec No 2():83-5. PubMed ID: 15968879 [TBL] [Abstract][Full Text] [Related]
8. [Beta-interferon clinical trials using MRI in patients with multiple sclerosis]. Lebrun C Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):761-7. PubMed ID: 11677396 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis. Boggild M; Ford H Clin Evid; 2002 Jun; (7):1195-207. PubMed ID: 12230737 [No Abstract] [Full Text] [Related]
10. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment. Lindquist S; Hassinger S; Lindquist JA; Sailer M Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957 [TBL] [Abstract][Full Text] [Related]